Stories Related to Glioblastoma Multiforme

Scientists solve century-old neuroscience mystery; answers may lead to epilepsy treatment

Nov. 6, 2018

Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy. The research team ...

VTCRI research team identifies a potential strategy in fight against brain cancer

Sept. 11, 2018

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help patients with a deadly form ...

Scientists identify new target for developing precision treatment in malignant brain tumors

Jan. 25, 2018

A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.

Virginia Tech Carilion Research Institute teams converge on strategies to defeat McCain’s form of brain cancer

July 26, 2017

Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of ...

Researchers find way to make resistant brain cancer cells sensitive to treatment

Nov. 16, 2015

Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.

Institute scientists visualize potential brain cancer treatments in real time

April 9, 2015

Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.

Going viral: Targeting brain cancer cells with a wound-healing drug

Dec. 12, 2014

At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it ...